DAWN vs NVDA · rev $131.2M vs P/E 58, rev $96.22B
Day One Biopharmaceuticals Inc (DAWN) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
DAWN currently screens at market cap $656.8M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the DAWN and NVDA stock pages for the full models.
Not investment advice.